MAT Clinics in Alaska: Methadone, Suboxone & Vivitrol Treatment
Looking for medication assisted treatment in Alaska? This guide helps you compare methadone, Suboxone and Vivitrol, find clinics, understand Alaska Medicaid and plan around long travel distances. A September 2026 federal listing identifies 6 Medicare-enrolled opioid treatment program locations across 4 Alaska cities.
On this page — jump to a section
- Alaska MAT at a Glance
- Get Help Finding a Clinic
- Find Clinics by City
- Treatment by Medication
- Methadone Rules
- Paying for Treatment
- Telehealth MAT
- Overdose and Access
- Areas with Limited Access
- Resources and Helplines
- Special Populations
- How to Choose a Clinic
- Frequently Asked Questions
- Sources and Editorial Standards
- Nearby State Guides
Alaska MAT at a Glance
What this means for you: Listed OTPs are concentrated in Southcentral and Southeast Alaska; for many off-road communities, local buprenorphine care and telehealth may be more practical first steps.
Get Help Finding a Clinic in Alaska
Need help exploring Alaska treatment options?
Speak with our treatment-navigation line about medication options, insurance questions, and possible next steps in Alaska.
Call 1-(347) 591-7540For an overdose or immediate danger, call 911. For crisis support, call or text 988. SAMHSA National Helpline: 1-800-662-4357.
MATClinicGuide.com provides education and treatment navigation, not medical treatment. Our phone line may connect you with participating providers or navigation partners, rather than the clinic shown here.
Find MAT Clinics by City in Alaska
Alaska has six Medicare-enrolled methadone OTP locations in Anchorage, Juneau, Sitka and Wasilla, according to the CMS September 8, 2026 provider file. Alaska is organized into boroughs and census areas rather than counties. Use the city directory to review each clinic’s published contact information.
Top cities for methadone clinics in Alaska
Alaska methadone OTP directory: 4 cities
Anchorage — 3 OTPs
Community Medical Services SAMHSA-certified OTP
4335 Laurel St, Anchorage, AK 99508-5338
Narcotic Drug Treatment Center, Inc. SAMHSA-certified OTP
1015 E 6th Ave, Anchorage, AK 99501-2748
Juneau — 1 OTP
Southeast Alaska Regional Health Consortium (SEARHC) SAMHSA-certified OTP
1720 Crest St, Juneau, AK 99801-8058
Sitka — 1 OTP
Southeast Alaska Regional Health Consortium (SEARHC) SAMHSA-certified OTP
700 Katlian Street, Ste F, Sitka, AK 99835-7359
Wasilla — 1 OTP
Community Medical Services SAMHSA-certified OTP
2521 E. Mountain Village Drive, Suites E and F, Wasilla, AK 99654-8525
Suboxone, buprenorphine and Vivitrol providers in Alaska
Suboxone doctors in Alaska and other buprenorphine providers may work in primary-care, psychiatry, addiction-medicine and tribal health settings. For people in rural communities without road connections, ask a local or tribal clinic whether buprenorphine treatment is available in person or by telehealth. Search FindTreatment.gov by ZIP code for current treatment services, including Vivitrol Alaska providers.
OTP listings use the CMS Medicare Opioid Treatment Program Providers file, version September 8, 2026. Call to confirm current certification, hours, intake and insurance.
MAT Treatment Options in Alaska by Medication
Methadone clinics in Alaska
Methadone for opioid use disorder is provided through certified opioid treatment programs in Alaska. The CMS September 2026 list shows three locations in Anchorage and one each in Wasilla, Juneau and Sitka. People often visit regularly when starting treatment, although clinical decisions and take-home arrangements vary. Long distances, ferry routes and air travel can complicate ongoing visits, so discuss a realistic schedule with the OTP before starting. Learn more in the methadone treatment guide and OTP overview.
Buprenorphine and Suboxone doctors in Alaska
Buprenorphine can be prescribed in qualified medical settings beyond methadone OTPs, including appropriate primary-care and tribal health settings. This can matter in Fairbanks, on the Kenai Peninsula and in communities not connected to the road system. Some appointments may take place using telehealth when federal and Alaska requirements are met; an in-person evaluation or local pharmacy pickup may still be necessary. Ask about induction instructions, pharmacies, follow-up visits and Alaska Medicaid. Read buprenorphine and Suboxone treatment and telehealth MAT.
Long-acting injectable buprenorphine: Sublocade and Brixadi
Sublocade and Brixadi are long-acting buprenorphine injections that may reduce the need for daily oral medication. In Alaska, a prescriber must assess medical suitability and arrange administration, so travel and pharmacy logistics can be important, especially outside Anchorage and Southeast Alaska. Clinics may have different ordering arrangements or injection schedules. Ask whether a local partner clinic can administer ongoing doses and whether Alaska Medicaid covers the specific product under your circumstances. See the Sublocade medication guide.
Naltrexone and Vivitrol in Alaska
Extended-release naltrexone (Vivitrol) is another medication option for opioid use disorder; it is not an opioid agonist. A person generally needs an opioid-free period before beginning to avoid precipitated withdrawal, and a clinician should supervise the transition. Residents of Southeast Alaska or rural boroughs can ask local addiction-medicine and tribal health practices whether injection visits can be arranged close to home. Alaska Medicaid’s OUD medication coverage requirements apply, while access and authorization details may differ. Compare options in the Vivitrol treatment guide.
| Medication | Where it is accessed in Alaska | Visits at start | Alaska Medicaid |
|---|---|---|---|
| Methadone | Certified OTP; listed in Anchorage, Wasilla, Juneau, Sitka | Often frequent early visits | Covered for OUD |
| Buprenorphine / Suboxone | Qualified office-based or other authorized prescriber | Assessment and follow-up; schedule varies | Covered for OUD |
| Sublocade / Brixadi | Qualified clinician for long-acting injection | Product-specific evaluation and dosing | Ask about product and authorization |
| Naltrexone / Vivitrol | Qualified prescribing and injection services | Opioid-free preparation and injection visits | Covered for OUD |
Methadone (OTP) Rules in Alaska
Alaska opioid treatment programs are overseen by the Alaska Department of Health Division of Behavioral Health and must follow federal SAMHSA/DEA requirements, including 42 CFR Part 8. Methadone treatment for OUD is dispensed through certified OTPs rather than ordinary retail prescribing. Alaska’s six CMS-listed locations offer four cities to contact when comparing travel and intake needs.
Intake and beginning treatment
Call the Anchorage, Juneau, Sitka or Wasilla OTP to ask about intake availability, appointments, identification, medication history and insurance documents. An evaluation will help determine whether methadone is appropriate and what monitoring is needed. Ask what the first week of visits would look like before making long-distance or ferry arrangements.
Take-home doses, guest dosing and transfers
Federal OTP rules updated in 2024 give clinicians more flexibility to make individualized decisions about take-home methadone. Alaska clinics still assess safety and follow applicable state requirements. Patients traveling between boroughs or remote communities can ask about guest dosing or transfers, but those arrangements require coordination and should never be assumed. The OTP guide explains the treatment model.
Paying for MAT in Alaska
MAT clinics that accept Medicaid in Alaska
Alaska Medicaid is administered by the Alaska Department of Health, and Alaska implemented Medicaid expansion on September 1, 2015, according to KFF. Federal Medicaid law requires coverage of medications for opioid use disorder, including methadone, buprenorphine and naltrexone. Ask the clinic how it handles billing, prior authorization and medication availability; participation and individual eligibility require confirmation. Visit the Alaska Department of Health for program information.
Alaska also operates a Section 1115 behavioral health demonstration supporting additional substance use disorder and mental health services. Its Behavioral Health Reform Waiver work includes residential and inpatient SUD treatment, crisis care, community outpatient services and recovery supports; a CMS-approved evaluation design was issued in December 2024.
| Service | Covered | Notes |
|---|---|---|
| Methadone for OUD | Yes | Through qualifying OTP services; eligibility and billing need confirmation |
| Buprenorphine for OUD | Yes | Product, pharmacy and authorization requirements may vary |
| Naltrexone for OUD | Yes | Ask about injection coverage and provider access |
| Outpatient SUD treatment | Yes | Services under Alaska behavioral health coverage |
| Residential SUD treatment | Yes | Included in Alaska’s Section 1115 behavioral health demonstration framework |
Medicare
Medicare Part B has an opioid treatment program benefit for eligible beneficiaries receiving covered OTP services. Take-home prescriptions for buprenorphine or naltrexone may involve Part D or another applicable benefit, with plan-specific restrictions. Alaska’s CMS provider list is a starting point rather than a guarantee of acceptance or immediate scheduling.
Private insurance
Private insurance may cover MOUD, but deductibles, networks, pharmacy benefits and prior-authorization rules vary. When comparing an Anchorage OTP with a local buprenorphine prescriber, ask the insurer about both medication coverage and the cost of repeated visits or travel.
No insurance or limited funds
People asking about free methadone clinics in Alaska can contact an OTP directly to discuss financial assistance, possible sliding-fee arrangements or referral resources. Tribal health organizations may be an important starting point for eligible Alaska Native and American Indian patients. The SAMHSA helpline can also help locate services; do not assume a specific clinic has free appointments.
For more detail, use insurance coverage guidance, MAT cost and insurance or verify insurance.
Need help exploring Alaska treatment options?
Speak with our treatment-navigation line about medication options, insurance questions, and possible next steps in Alaska.
Call 1-(347) 591-7540For an overdose or immediate danger, call 911. For crisis support, call or text 988. SAMHSA National Helpline: 1-800-662-4357.
MATClinicGuide.com provides education and treatment navigation, not medical treatment. Our phone line may connect you with participating providers or navigation partners, rather than the clinic shown here.
Telehealth MAT in Alaska
Telehealth Suboxone in Alaska may help residents of the Interior, Southwest and Arctic regions reach a prescribing clinician without repeated long-distance trips. Federal DEA/HHS controlled-medication telemedicine flexibilities extend through December 31, 2026; clinicians must also follow applicable Alaska and federal requirements. Telehealth is not an automatic promise of a prescription, coverage or treatment availability.
A provider may conduct assessments or follow-ups remotely where permitted, but medication access may still require a pharmacy and occasional in-person care. Methadone for OUD remains tied to an OTP, rather than a telehealth prescription filled at an ordinary pharmacy. Ask rural or tribal health practices about local coordination and visit the telehealth MAT guide.
Opioid Overdose in Alaska: Why Access Matters
Alaska recorded 340 drug overdose deaths in 2024, according to CDC NCHS data reported by USAFacts. The age-adjusted all-drug overdose death rate was 45.1 per 100,000, compared with the national rate of 23.1, according to CDC NCHS/KFF. Alaska’s opioid overdose death rate was 37.0 per 100,000, compared with 16.0 nationally in 2024. These figures emphasize the need for local medication treatment, naloxone and practical care pathways.
The Alaska all-drug rate rose from 17.8 in 2019 to a high of 49.4 in 2023, then fell to 45.1 in 2024. That reduction is encouraging, but the 2024 rate remained much higher than the U.S. figure. For people far from Anchorage or Southeast Alaska, having access to telehealth, pharmacy services and tribal health clinics can be especially important.
| Year | Alaska all-drug rate | Alaska opioid rate |
|---|---|---|
| 2019 | 17.8 | 10.9 |
| 2020 | 22.0 | 15.2 |
| 2021 | 35.6 | 27.6 |
| 2022 | 34.3 | 25.1 |
| 2023 | 49.4 | 40.1 |
| 2024 | 45.1 | 37.0 |
Project HOPE distributes free naloxone through partner locations across Alaska. Learn about overdose prevention and naloxone.
Areas of Alaska with Limited MAT Access
The September 2026 CMS list shows methadone OTPs only in Anchorage, Wasilla, Juneau and Sitka. The regional suggestions below are travel-planning starting points, not a determination of the nearest clinic for every community; confirm the route, ferry or flight arrangements and clinic admission requirements before travel.
Interior Alaska
Regions: Fairbanks North Star Borough, Denali, Southeast Fairbanks and Yukon-Koyukuk.
OTP cities to explore: Anchorage or Wasilla; investigate local buprenorphine and telehealth first.
Kenai Peninsula and Gulf Coast
Regions: Kenai Peninsula Borough, Kodiak Island and the Valdez-Cordova area.
OTP cities to explore: Anchorage or Wasilla; travel may involve long drives, flights or ferries.
Southwest and Yukon-Kuskokwim
Regions: Bethel, Kusilvak, Dillingham, Bristol Bay, Lake and Peninsula, and the Aleutians.
OTP cities to explore: Anchorage, often requiring air travel.
Northern and Arctic Alaska
Regions: North Slope, Northwest Arctic and Nome.
OTP cities to explore: Anchorage, commonly reached by air.
Southeast beyond Juneau and Sitka
Regions: Ketchikan, Petersburg, Wrangell, Haines, Skagway and Prince of Wales–Hyder.
OTP cities to explore: Juneau or Sitka; travel may involve ferry or air connections.
For communities without road access, ask nearby primary-care or tribal clinics about buprenorphine, telehealth arrangements and naloxone. Project HOPE has partner sites in communities including Bethel, Nome, Kotzebue, Utqiagvik and Fort Yukon.
Alaska Resources and Helplines
The Alaska Department of Health Division of Behavioral Health coordinates state behavioral health resources. Project HOPE makes naloxone available through a statewide network of partners, including rural Alaska communities.
Division of Behavioral Health
350 Main Street, Suite 214, Juneau, AK 99801 · (907) 465-3370 · (800) 465-4828 · Agency website
Anchorage DBH contact
(907) 269-3600 · Toll-free (800) 770-3930
Project HOPE naloxone
Free naloxone kits with two Narcan doses, gloves, instructions and carrying case; partner sites in roughly 49 communities. Project HOPE · doh.projecthope.info@alaska.gov
National treatment and crisis help
SAMHSA: 1-800-662-4357. Crisis support: call/text 988. An overdose emergency: 911.
Naloxone and Alaska’s Good Samaritan law
Alaska Statute 11.71.311 protects people seeking emergency help for a suspected overdose from prosecution for certain possession offenses under specified conditions. The person seeking help must remain at the scene and cooperate with responders, including providing identification. This protection has limits; do not delay calling 911. Project HOPE kits can also be requested through iknowmine.org.
MAT for Special Populations in Alaska
Pregnant and postpartum people
Pregnant or postpartum Alaska residents can discuss MOUD with a qualified prenatal-care and addiction-treatment team. Methadone and buprenorphine are established treatment options in pregnancy when clinically appropriate; stopping medication without professional supervision can pose risks. For a patient outside Anchorage, ask whether local obstetric services can coordinate with an OTP or a buprenorphine prescriber.
Veterans
Alaska veterans can ask their VA care team about evaluation and treatment for opioid use disorder and about coordinating medication services. Veterans in interior or off-road communities may need to discuss remote follow-up, travel support or care closer to home. The six publicly listed methadone OTP locations are not a comprehensive list of VA medication services.
Adolescents and young adults
Young people in Alaska need developmentally appropriate screening and treatment planning. Medication eligibility and decisions depend on age, clinical assessment and applicable prescribing requirements. Families can ask a local clinician, tribal health service or addiction specialist about available youth-oriented care. The family support guide offers a starting point for supportive conversations.
People leaving jail or prison
A person returning to an Alaska community after incarceration may need uninterrupted access to medication, prescriptions and follow-up appointments. Coordination before release is especially important where the nearest listed OTP is in Anchorage, Wasilla, Juneau or Sitka. Ask the correctional health or community care team to organize records, naloxone and a specific treatment appointment.
Rural residents and off-road communities
In many Alaska villages, traveling to a methadone OTP requires air or ferry transportation. A local primary-care clinic, telehealth buprenorphine prescriber or tribal health service may be a more practical access point. Ask about reliable internet or phone visits, local medication pickup, weather-related interruptions and a plan for clinical follow-up.
Alaska Native and American Indian patients
Tribal health organizations can be important sources of culturally appropriate opioid use disorder care. Southeast Alaska Regional Health Consortium (SEARHC) appears in the federal OTP list at both Juneau and Sitka locations. IHS-eligible patients can ask their tribal health provider what medication treatment and referrals are available locally and how care can be coordinated during travel.
How to Choose a MAT Clinic in Alaska
A useful Alaska treatment choice depends on medication fit, clinic availability, insurance and whether visits are workable from your home community. The right questions can differ between methadone OTPs and office-based buprenorphine providers.
Questions to ask a methadone OTP
- Are you currently accepting new patients, and how does intake work?
- How often would I need to attend during my first weeks?
- What is your approach to clinically appropriate take-home doses?
- Can your team arrange guest dosing or a transfer if I must travel?
- Do you bill Alaska Medicaid, Medicare or my private insurance?
Questions to ask a buprenorphine provider
- Do you prescribe buprenorphine for opioid use disorder?
- Are video or phone appointments available for my Alaska location?
- Which pharmacies can dispense my prescribed medication?
- What follow-up, labs or in-person visits may be required?
- Can you coordinate care with my local or tribal health clinic?
What happens at a first visit?
- Explain your symptoms, medication history and treatment goals.
- Discuss medical history, other medications and safety considerations.
- Review treatment choices and a clinician-directed start plan.
- Confirm follow-up dates, cost, medication pickup and travel plans.
For a fuller overview, see OUD medications, MAT vs. MOUD, how long treatment lasts and counseling and medication.
Need help exploring Alaska treatment options?
Speak with our treatment-navigation line about medication options, insurance questions, and possible next steps in Alaska.
Call 1-(347) 591-7540For an overdose or immediate danger, call 911. For crisis support, call or text 988. SAMHSA National Helpline: 1-800-662-4357.
MATClinicGuide.com provides education and treatment navigation, not medical treatment. Our phone line may connect you with participating providers or navigation partners, rather than the clinic shown here.
FAQs About MAT Clinics in Alaska
How many methadone clinics are in Alaska?
The CMS Medicare OTP provider list dated September 8, 2026 includes six locations in four Alaska cities: three in Anchorage and one each in Juneau, Sitka and Wasilla. This is a count of Medicare-enrolled OTP locations in that federal file, not a count of every possible treatment service. Contact a listed clinic to confirm its current services and intake procedures.
Where are methadone clinics in Anchorage, Alaska?
The September 2026 CMS list identifies three Anchorage OTP locations: Community Medical Services at 4335 Laurel Street, Narcotic Drug Treatment Center, Inc. at 1015 East 6th Avenue, and WCHS, Inc. at 3230 C Street. Their published telephone numbers and directions appear in the city directory above. Ask each program about scheduling, transportation and insurance.
Does Alaska Medicaid cover Suboxone and methadone?
Yes. Federal Medicaid requirements include coverage for medications used to treat opioid use disorder, including buprenorphine and methadone. Alaska Medicaid operates through the Alaska Department of Health; individual eligibility, pharmacy arrangements and authorization requirements should be checked. Alaska expanded Medicaid in 2015 and also uses a Section 1115 demonstration for behavioral health services.
Can I get telehealth Suboxone in Alaska?
Telehealth buprenorphine treatment may be available in Alaska when a prescribing clinician follows applicable requirements. Federal DEA/HHS prescribing flexibilities remain in effect through December 31, 2026, but Alaska rules and clinical needs may add steps. Ask a local or tribal health clinic whether it coordinates remote visits and which pharmacy can fill prescriptions.
Are there free methadone clinics in Alaska?
Some people may qualify for financial assistance or coverage, but a free appointment at a specific Alaska methadone clinic should not be assumed. The CMS September 2026 list contains OTPs in Anchorage, Juneau, Sitka and Wasilla. Ask programs about Alaska Medicaid, payment arrangements and referrals. The SAMHSA National Helpline at 1-800-662-4357 can help with treatment searches.
Are there methadone clinics in Fairbanks, Alaska?
The CMS September 8, 2026 Medicare OTP list does not identify a Fairbanks location. It lists Alaska locations in Anchorage, Wasilla, Juneau and Sitka. For Fairbanks residents, office-based buprenorphine, local clinical services and telehealth may be useful alternatives to investigate; a clinician can advise which medication treatment is appropriate.
Where can I find Vivitrol treatment in Alaska?
Alaska residents seeking Vivitrol can search FindTreatment.gov and contact local addiction-medicine, primary-care or tribal health clinicians to ask about injectable naltrexone. An opioid-free period is typically required before starting to avoid withdrawal complications. Confirm clinical eligibility, injection availability and Alaska Medicaid coverage details with the provider.
How can rural Alaska residents access opioid treatment?
Residents of northern, western and off-road communities may have no practical road access to the six CMS-listed OTP locations. Local or tribal health programs, office-based buprenorphine and telehealth can be valuable starting points. Ask about medicine pickup, follow-up, weather disruptions and Project HOPE naloxone availability in communities including Bethel, Nome and Kotzebue.
Where can I get free naloxone in Alaska?
Alaska Project HOPE distributes free naloxone kits through partner sites across the state, including rural communities. Its state program reports roughly 194 partners in about 49 communities; kits include two Narcan doses and supplies. Check the Project HOPE website for current locations or ordering options. If you suspect an overdose, call 911 immediately.
What is the overdose death rate in Alaska?
Alaska’s 2024 age-adjusted all-drug overdose death rate was 45.1 per 100,000, according to CDC NCHS data reported through KFF, versus 23.1 nationally. The state opioid-related rate was 37.0 per 100,000, compared with 16.0 nationally. These public-health rates describe populations, not the risks or outcome for an individual seeking treatment.
Sources, Methodology & Editorial Standards
Clinic locations and phones were taken from the CMS Medicare Opioid Treatment Program Providers file dated September 8, 2026, grouped by city and checked for exact-address duplicates. The file concerns Medicare-enrolled OTP locations; it should not be interpreted as a full inventory of office-based buprenorphine treatment in Alaska. Public health rates, policy information and resource descriptions are from the sources below.
- CMS, Medicare Opioid Treatment Program Providers (Sep 8, 2026)
- KFF, Medicaid expansion status (Oct 2026)
- Alaska 1115 demonstration renewal public notice (2023)
- CMS-approved Alaska behavioral health evaluation design (Dec 2024)
- Alaska Division of Behavioral Health contacts
- Project HOPE naloxone program
- Project HOPE partner locations
- Alaska Good Samaritan statute, 2014 (AS 11.71.311)
- KFF / CDC NCHS overdose rates, 2019–2024
- USAFacts / CDC, Alaska overdose deaths (2024)
MATClinicGuide.com is an educational and treatment-navigation resource, not a medical provider; we do not own or operate any clinic on this page, diagnose conditions, prescribe medication or promise treatment results. This information does not replace individualized clinical care. Call the clinic itself to confirm medication services, insurance and admission requirements.
Calls to our helpline reach MATClinicGuide’s treatment-navigation line, not the clinic listed in a directory row. Calls may be handled by or routed to participating treatment providers or navigation partners. In an emergency call 911; for crisis support call or text 988. Review our editorial policy, medical disclaimer and advertising and referral disclosure.
MAT Clinics in Nearby States
Alaska has no bordering U.S. states; Washington and Oregon are Lower-48 states that some Alaska residents may consider when traveling for care.